At InjectCo, compounded GLP-1 medications are only prescribed when clinically appropriate as part of a structured, physician-guided weight loss program
M., & Luo, X
[DOI] [PubMed] [Google Scholar] Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, Smith JD, DiDonato JA, Chen J, Li H, Wu GD, Lewis JD, Warrier M, Brown JM, Krauss RM, Tang WH, Bushman FD, Lusis AJ, Hazen SL
Weight loss can vary among patients
The SURMOUNT-OSA master protocol comprised two, 52-week, randomized, double-blind, placebo-controlled phase 3 studies (study 1 and study 2) and demonstrated a significant reduction of a number of cardiometabolic risk measures in participants with OSA and obesity following treatment with tirzepatide
Both inject cleanly and absorb efficiently when administered subcutaneously in the abdomen, thigh, or upper arm